Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (TNFALPHA) monoclonal antibody for Crohn's disease

被引：14
|
作者：
Bank, L
Hunt, B
机构：
[1] Univ Med Associates, Binghamton, NY USA
[2] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2002年 / 97卷 / 09期
关键词：
D O I：
10.1016/S0002-9270(02)05276-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
793
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [31] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
    Salvatore Gulli
    Carlo Arrigo
    Loredana Bocchino
    Lucia Morgante
    Donatella Sangari
    Irene Castagna
    Gian Filippo Bagnato
    BMC Musculoskeletal Disorders, 4
  • [32] Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: A case report
    Hassard, PV
    Binder, SW
    Nelson, V
    Vasiliauskas, EA
    GASTROENTEROLOGY, 2001, 120 (04) : 995 - 999
  • [33] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
    Gulli, S
    Arrigo, C
    Bocchino, L
    Morgante, L
    Sangari, D
    Castagna, I
    Bagnato, GF
    BMC MUSCULOSKELETAL DISORDERS, 2003, 4 (1)
  • [34] Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease
    Kupcova, V
    Turecky, L
    Detková, Z
    Príkazská, M
    Keleová, A
    PHYSIOLOGICAL RESEARCH, 2003, 52 (01) : 89 - 93
  • [35] Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy
    Ong, David E. H.
    Kamm, Michael A.
    Hartono, Juanda Leo
    Lust, Mark
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (10) : 1595 - 1599
  • [36] Intestinal ultrasound and magnetic resonance enterography for monitoring response to anti-tumor necrosis factor treatment of Crohn's disease strictures: The STRIDENT study
    Lovett, G.
    Schulberg, J.
    Hamilton, A. L.
    Wright, E.
    Sutherland, T. R.
    Ross, A.
    Kamm, M. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 146 - 147
  • [37] Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
    Rutgeerts, P
    D'Haens, G
    Targan, S
    Vasiliauskas, E
    Hanauer, SB
    Present, DH
    Mayer, L
    Van Hogezand, RA
    Braakman, T
    DeWoody, KL
    Schaible, TF
    Van Deventer, SJH
    GASTROENTEROLOGY, 1999, 117 (04) : 761 - 769
  • [38] Clinical and Endoscopic Response to Anti-Tumor Necrosis Factor-Alpha Antibody Therapy in a Patient With Cronkhite-Canada Syndrome
    Roghani, Roham Salman
    De Castro, Joline
    Ajumobi, Adewale B.
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
  • [39] Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFα) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathy
    Saeki, Y
    Ohshima, S
    Mima, T
    Sasai, M
    Nishioka, K
    Shimizu, M
    Suemura, M
    McCloskey, R
    Kishimoto, T
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1998, 27 (04) : 303 - 305
  • [40] Vedolizumab Resulted in Resolution of Anti-tumor Necrosis Factor Psoriasis and Sustained Clinical and Endoscopic Remission of Crohn's Colitis
    White, Betty
    Holderman, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S293 - S293
12345